Insider Stock Trading History of Nutter Brad


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Nutter Brad since year 2005. The trader's CIK number is 1225293. At the time of this reporting, Nutter Brad is the President & CEO of Haemonetics Corp . (stock ticker symbol HAE). See this page for all insider trading activities at Haemonetics Corp .


Stock purchases, sales, and option exercises reported by insider Nutter Brad since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2010-03-25 HAE Haemonetics Corp Option Ex 26,872 41.15 1,105,782
2010-03-25 HAE Haemonetics Corp Sale 26,872 57.00 1,531,730
2010-03-24 HAE Haemonetics Corp Sale 100 57.00 5,700
2010-03-23 HAE Haemonetics Corp Sale 30,700 57.00 1,749,900
2010-03-24 HAE Haemonetics Corp Option Ex 100 41.15 4,115
2010-03-22 HAE Haemonetics Corp Sale 142,328 57.00 8,112,696
2010-03-23 HAE Haemonetics Corp Option Ex 30,700 41.15 1,263,305
2010-03-22 HAE Haemonetics Corp Option Ex 142,328 41.15 5,856,797
2009-02-17 HAE Haemonetics Corp Option Ex 100,000 26.10 2,610,500
2009-02-17 HAE Haemonetics Corp Sale 100,000 59.85 5,984,900
2008-10-15 HAE Haemonetics Corp Sale 50,000 56.33 2,816,400
2008-10-15 HAE Haemonetics Corp Option Ex 50,000 21.91 1,095,500
2008-09-15 HAE Haemonetics Corp Sale 50,000 63.75 3,187,600
2008-09-15 HAE Haemonetics Corp Option Ex 50,000 21.91 1,095,500
2008-08-15 HAE Haemonetics Corp Option Ex 50,000 21.91 1,095,500
2008-08-15 HAE Haemonetics Corp Sale 50,000 61.06 3,052,750
2008-07-22 HAE Haemonetics Corp Option Ex 50,000 21.91 1,095,500
2008-07-22 HAE Haemonetics Corp Sale 50,000 55.00 2,750,000
2008-06-16 HAE Haemonetics Corp Option Ex 50,000 21.91 1,095,500
2008-06-16 HAE Haemonetics Corp Sale 50,000 57.13 2,856,300
2008-05-16 HAE Haemonetics Corp Sale 50,000 55.05 2,752,600
2008-05-16 HAE Haemonetics Corp Option Ex 50,000 21.91 1,095,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Nutter Brad (President & CEO of Haemonetics Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.